Browsing byAuthorGorrell, MD
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
| 2018-10-04 | An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis | Roediger, B; Lee, Q; Tikoo, S; Cobbin, JCA; Henderson, JM; Jormakka, M; O'Rourke, MB; Padula, MP; Pinello, N; Henry, M; Wynne, M; Santagostino, SF; Brayton, CF; Rasmussen, L; Lisowski, L; Tay, SS; Harris, DC; Bertram, JF; Dowling, JP; Bertolino, P; Lai, JH; Wu, W; Bachovchin, WW; Wong, JJL; Gorrell, MD; Shaban, B; Holmes, EC; Jolly, CJ; Monette, S; Weninger, W |
| - | Differential Effects of ‘Vaping’ on Lipid and Glucose Profiles and Liver Metabolic Markers in Obese Versus Non-obese Mice | Chen, H; Li, G; Chan, YL; Zhang, HE; Gorrell, MD; Pollock, CA; Saad, S; Oliver, BG |
| 2019-01-01 | Identification of novel natural substrates of fibroblast activation protein-alpha by differential degradomics and proteomics | Zhang, HE; Hamson, EJ; Koczorowska, MM; Tholen, S; Chowdhury, S; Bailey, CG; Lay, AJ; Twigg, SM; Lee, Q; Roediger, B; Biniossek, ML; O'Rourke, MB; McCaughan, GW; Keane, FM; Schilling, O; Gorrell, MD |
| 2022-01-22 | Sitagliptin Is More Effective Than Gliclazide in Preventing Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease. | Ren, J; Wang, X; Yee, C; Gorrell, MD; McLennan, SV; Twigg, SM |
| 2022-09 | Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetes. | Ren, J; Wang, X; Parry, SN; Yee, C; Gorrell, MD; McLennan, SV; Twigg, SM |
